Adrenal gland cancer is a rare cancer that starts in one or both adrenal glands. People with adrenal gland cancer may notice belly pain, a feeling of fullness, weight changes, or signs of excess hormones like high blood pressure and new facial or body hair. It can occur at any age but is seen more often in adults, and some tumors grow quickly. Treatment often includes surgery to remove the tumor and may involve medicines, radiation, or chemotherapy. The outlook varies by stage and tumor type, but advances in care mean people often manage well with treatment.
Overview
Adrenal gland cancerSymptoms
Adrenal gland cancer may cause early vague issues: fatigue, abdominal fullness or pain, and unexplained weight loss. Hormone-making tumors can trigger high blood pressure, headaches, muscle weakness, menstrual changes, or be silent—early symptoms of adrenal gland cancer are often minimal.
Outlook and prognosis
Many living with adrenal gland cancer do well when it’s found early and surgically removed, sometimes with focused medicines afterward. Outcomes vary by tumor type and spread. Regular scans and hormone checks help catch changes early and guide timely treatment.
Causes and risk factors
Adrenal gland cancer often has no clear cause. Risk increases with inherited syndromes (Li‑Fraumeni, Lynch, Beckwith‑Wiedemann) or family history, and is higher in children and mid‑adults, slightly more in women. Environmental or lifestyle links are uncertain; therapeutic radiation may contribute.
Genetic influences
Genetics play a meaningful role in adrenal gland cancer, though most cases are not inherited. Certain inherited syndromes and gene changes can raise risk or shape tumor behavior. Genetic testing may guide surveillance, treatment choices, and inform family members’ risk.
Diagnosis
Adrenal gland cancer is usually found with imaging scans after symptoms or an incidental mass, and hormone blood/urine tests. The diagnosis of adrenal gland cancer is confirmed mainly by surgical pathology after tumor removal; additional scans check spread.
Treatment and drugs
Adrenal gland cancer treatment often combines surgery to remove the tumor with carefully chosen medicines like targeted therapy, immunotherapy, or mitotane, and sometimes radiation. Many also receive steroid replacement to balance hormones. Care is tailored by stage and hormone activity.
Symptoms
Adrenal gland cancer can cause symptoms from hormone changes or from a growing mass in the belly. Early symptoms of adrenal gland cancer are often vague—things like fatigue, new high blood pressure, or body changes that don’t match your routine. Symptoms vary from person to person and can change over time. If new changes build over weeks to months or begin to affect daily life, consider making an appointment.
New or suddenly harder-to-control blood pressure can happen with adrenal gland cancer when the tumor makes certain hormones. You might notice headaches or shortness of breath.
A rounder face, more fat around the neck and belly, and thinning skin can occur in adrenal gland cancer when cortisol is high. Purple stretch marks and easy bruising may show up.
Climbing stairs or getting up from a low seat can start to feel harder. This often comes from muscle loss linked to hormone changes.
Higher-than-usual blood sugar can bring more thirst and frequent urination. Some people feel extra hungry or unusually tired.
How people usually first notice Adrenal gland cancer?
Many people first notice adrenal gland cancer because of vague, stubborn symptoms that don’t fit their usual pattern, like fatigue that doesn’t lift, unexplained weight changes, or a new ache in the back or belly. Others are alerted by hormone-related changes the tumor can cause, such as high blood pressure that’s hard to control, new or worsening diabetes, muscle weakness, facial flushing, or, in some, rapid changes in body hair, acne, or menstrual irregularities; children may show early puberty signs. Sometimes there are no clear symptoms at first, and it’s found incidentally on an imaging scan done for another reason.
Types of Adrenal gland cancer
Adrenal gland cancer doesn’t look the same in everyone, and doctors recognize several types based on where the tumor starts and how the cells behave. These types can feel different day to day—some bring hormone-related changes, while others stay “silent” until they grow larger. Clinicians often describe them in these categories: adrenal cortical carcinoma, pheochromocytoma and paraganglioma, and adrenal metastases from cancers that started elsewhere. Knowing the main types of adrenal gland cancer helps explain why symptoms vary and what tests or treatments may be recommended when discussing types of adrenal gland cancer.
Adrenocortical carcinoma
This rare cancer starts in the outer layer of the adrenal gland that makes cortisol, aldosterone, and sex hormones. Some tumors make extra hormones, causing signs like weight gain, new or worsening high blood pressure, facial hair changes, or menstrual changes. Others make no hormones and mainly cause belly or back discomfort as they grow.
Pheochromocytoma
This tumor begins in the inner part of the adrenal gland that makes adrenaline-like hormones. It often triggers sudden pounding headaches, sweating, palpitations, and spikes in blood pressure that can come in bursts. Between bursts, some people feel mostly well.
Paraganglioma
These are closely related tumors that form in nerve tissue outside the adrenal glands but can behave like adrenal tumors. Symptoms mirror pheochromocytoma when the tumor releases adrenaline-like hormones, with episodic high blood pressure, tremor, and anxiety-like feelings. Tumors that do not release hormones may present with a painless mass or pressure symptoms.
Adrenal metastases
These are cancers that have spread to the adrenal gland from another site, such as lung, melanoma, kidney, or colon. They typically do not make hormones and may be found on scans done for another reason. When large, they can cause dull side or back pain or fullness.
What genetics can tell you about symptoms
Certain inherited variants in TP53 (Li-Fraumeni syndrome) or MEN1 can raise the chance of adrenal tumors, which may cause symptoms like high blood pressure, weight gain, muscle weakness, and headaches from excess hormones. Lynch syndrome genes (e.g., MSH2, MLH1) also modestly increase risk, linking adrenal tumors to fatigue, abdominal pain, or early puberty in children when hormones surge.
Causes and risk factors
Most cases of adrenal gland cancer arise by chance, and clear links to smoking, alcohol, or diet have not been shown.
Some people inherit gene changes that raise risk, such as Li-Fraumeni, Lynch, or Beckwith‑Wiedemann syndromes.
Risk can be higher in very young children and in adults in their 40s or 50s.
It is slightly more common in women and can run in families.
Prior radiation exposure is a possible environmental risk, and doctors distinguish between risk factors for adrenal gland cancer you can change and those you can’t.
Environmental and biological risk factors
Adrenal gland cancer is rare, and most people never develop it. Doctors often group risks into internal (biological) and external (environmental). Because it’s uncommon, early symptoms of adrenal gland cancer can be easy to miss, so doctors may consider risk patterns alongside the exam. What we know today points to a few biological patterns and only limited environmental links.
Risk is highest in early childhood and again in mid-adulthood, creating a two-peak pattern. Outside these ages, adrenal gland cancer is even less common. Doctors may weigh age when deciding on testing.
This cancer occurs slightly more often in females than males. The reason is not clear, but differences in hormone biology may contribute.
High-dose radiation to the belly during childhood cancer treatment can raise the chance of several rare abdominal tumors later in life. Adrenal gland cancer remains uncommon even with this exposure, but your care team may keep it in mind when reviewing history.
No specific workplace or environmental chemical has been consistently proven to raise risk. Research continues, and findings so far have been mixed.
Genetic risk factors
Some adrenal gland cancers occur because of inherited changes in certain genes. Carrying a genetic change doesn’t guarantee the condition will appear. If your family has a pattern of endocrine tumors or early cancers, a genetics professional can discuss testing and the inherited risk of adrenal gland cancer.
Li-Fraumeni syndrome: This inherited condition comes from changes in the TP53 gene. It raises the chance of adrenocortical carcinoma, a type of adrenal gland cancer, especially in children. Families may notice multiple cancers at young ages.
Beckwith-Wiedemann: This childhood overgrowth syndrome increases the risk of adrenocortical carcinoma, an adrenal gland cancer. It involves changes in growth-control genes on chromosome 11, often affecting IGF2. Children with this condition may be offered tumor screening.
Lynch syndrome: Best known for colon and uterine cancers, this syndrome can rarely involve adrenocortical carcinoma, an adrenal gland cancer. It stems from changes in DNA repair genes like MLH1, MSH2, MSH6, or PMS2. Family history of early cancers can be a clue.
MEN1 syndrome: People with MEN1 can develop adrenal cortical tumors. Most are noncancerous, but adrenocortical carcinoma, an adrenal gland cancer, can occur. Doctors may advise periodic imaging.
Familial polyposis: Familial adenomatous polyposis (APC) can rarely be linked to adrenocortical carcinoma. Risk is low but higher than in the general population. Genetic counseling can guide monitoring.
MEN2 (RET): This syndrome raises the chance of adrenal medulla tumors called pheochromocytomas. Some become cancerous adrenal gland tumors or spread beyond the adrenal. Testing and follow-up usually start in early adulthood.
VHL syndrome: Von Hippel–Lindau syndrome increases the risk of pheochromocytoma in the adrenal gland. Many tumors are benign, but some can be malignant. Regular screening helps catch changes early.
Neurofibromatosis type 1: People with NF1 have a higher chance of adrenal gland tumors called pheochromocytomas. Most are noncancerous, but cancers can occur. Genetic counseling can clarify personal risk.
SDHB variants: Changes in the SDHB gene strongly raise the risk of paraganglioma and adrenal pheochromocytoma. These tumors carry a higher chance of becoming malignant compared with other gene causes. Close, lifelong follow-up is usually recommended.
Other pheo genes: Changes in SDHD, SDHC, MAX, TMEM127, FH, or EPAS1 can also lead to adrenal gland tumors. The chance of cancer varies by gene. A genetics team can tailor screening to the specific change.
Familial clustering: Having a close relative with adrenal gland cancer may signal an inherited risk even without a named syndrome. A genetics professional can review your family tree and discuss testing. This can help plan personalized screening.
Lifestyle risk factors
Evidence for lifestyle risk factors for Adrenal gland cancer is limited, but certain habits can influence overall cancer risk, hormone balance, and treatment outcomes. Understanding how lifestyle affects Adrenal gland cancer can help optimize surgery readiness, symptom control, and recovery. The elements below reflect plausible, evidence-informed areas where habits may matter, even if direct causal links to this specific cancer are not firmly proven.
Smoking is associated with higher overall cancer risk and has been linked to adrenal tumors in some observational studies. Quitting may improve surgical healing and reduce complications during chemotherapy or radiation.
Heavy drinking increases general cancer risk and can impair liver function that helps process adrenal hormones and cancer medicines. Limiting alcohol supports safer treatment and smoother recovery.
Obesity affects insulin and adrenal steroid signaling, which may influence tumor behavior and symptom patterns. Reaching a healthier weight can lower surgical risk and improve long-term cancer outcomes.
Regular movement reduces inflammation and improves insulin sensitivity relevant to hormone-driven cancers. Better fitness can shorten hospital stays and speed recovery after adrenal surgery.
Risk prevention
There’s no sure way to prevent adrenal gland cancer, but you can lower risks and catch problems earlier. For most people, broad healthy habits matter; for those with inherited risks, specialized monitoring can help. Some prevention is universal, others are tailored to people with specific risks. If you ever notice unusual hormone-related changes, early contact with your care team can speed evaluation.
If close relatives have adrenal tumors or certain inherited syndromes, consider genetic counseling. Results can guide whether you need tailored screening for adrenal gland cancer.
People with a known inherited risk may benefit from regular imaging, such as MRI or ultrasound, and periodic hormone testing. This can find adrenal gland cancer earlier, when treatment options are broader.
Not smoking lowers overall cancer risk and supports heart and lung health for future treatments. If you smoke, quitting reduces complications that can mask adrenal symptoms.
Regular movement and balanced eating help steady hormones and blood pressure. These habits support overall cancer prevention and make it easier to spot changes that could relate to adrenal gland cancer.
Transmission
Adrenal gland cancer is not contagious—you can’t “catch” it from someone else through touch, coughing, sex, or everyday contact. Most cases aren’t inherited; they happen when gene changes build up in adrenal cells over time. A smaller share occurs in people born with an inherited gene change that raises risk; this can be passed from a parent to a child, and sometimes the change appears for the first time in a family. If you’re wondering about how adrenal gland cancer is inherited, it’s usually about genetic risk being passed on—not the cancer itself. Families with several related cancers or adrenal tumors may want to ask about genetic counseling and testing.
When to test your genes
Consider genetic testing if you were diagnosed with adrenal gland cancer at a young age, have bilateral or multiple adrenal tumors, or there’s a family history of adrenal, thyroid, kidney, or brain tumors. Testing can uncover inherited syndromes (like Li-Fraumeni or MEN2) that guide screening and treatment. Ask a genetic counselor to time and choose the right test.
Diagnosis
Adrenal gland cancer often comes to attention when everyday issues like hard‑to‑control blood pressure, rapid weight changes, or muscle weakness don’t add up. Doctors usually begin with your story and a focused exam, then order tests based on what they find. In practice, how Adrenal gland cancer is diagnosed often involves a combination of hormone testing and detailed imaging. Timelines vary; some people get answers quickly, while others need a few steps to confirm what’s going on.
Your provider reviews symptoms such as headaches, flushing, fatigue, or changes in weight or body hair. They check blood pressure, look for skin changes, and feel the abdomen for any masses.
Blood tests look for excess cortisol, aldosterone, and adrenal sex hormones that tumors can overproduce. Results help point toward the tumor type and guide the next tests.
Collecting urine over 24 hours can measure adrenaline‑like hormones and their breakdown products. This helps identify hormone‑secreting tumors that may not show up clearly with a single blood draw.
Imaging maps the adrenal glands and nearby structures in detail. It helps show the size, shape, and features that suggest cancer versus a benign growth.
Stages of Adrenal gland cancer
Doctors use staging to describe how far adrenal gland cancer has grown and whether it has spread. Early and accurate diagnosis helps you plan ahead with confidence. Staging relies on imaging scans and what surgeons and pathologists find during procedures; early symptoms of adrenal gland cancer do not determine stage. The most commonly used system groups it into four stages, based on tumor size, nearby involvement, and distant spread.
Stage I
Localized: The tumor is 5 cm (about 2 inches) or smaller and limited to the adrenal gland. There is no spread to lymph nodes or other organs.
Stage II
Larger tumor: The tumor is larger than 5 cm (more than 2 inches) but still only within the adrenal gland. There is no spread to lymph nodes or distant organs.
Stage III
Regional spread: The cancer has grown into nearby tissues or major veins, or has reached nearby lymph nodes. It has not spread to distant parts of the body.
Stage IV
Distant spread: The cancer has spread to distant organs such as the liver, lungs, or bones. The main tumor can be any size, and care often focuses on control and symptom relief alongside treatment of the spread.
Outlook and prognosis
Daily routines often adapt as people with adrenal gland cancer move through treatment—fatigue can slow mornings, blood pressure meds may shift, and follow-up scans become part of the calendar. The outlook is not the same for everyone, but it depends a lot on tumor type (cortisol- or hormone‑producing vs. non‑functional), stage at diagnosis, and how completely surgeons can remove it. Doctors call this the prognosis—a medical word for likely outcomes. When tumors are found early and fully removed, long-term control is possible; if cancer has spread, care focuses on shrinking or stabilizing it and easing hormone-related symptoms.
Here’s what research and experience suggest about the future. Localized adrenal gland cancer that is fully resected can have multi‑year survival, while advanced disease has a lower survival rate and higher chance of coming back. Some people experience long symptom‑free stretches after surgery, while others notice cycles of treatment and recovery as scans guide next steps. Hormone‑producing tumors may add risks like high blood pressure, diabetes, or infections, which can affect mortality if not well managed. Early symptoms of adrenal gland cancer—such as unexplained weight gain, muscle weakness, new high blood pressure, or deep fatigue—often reflect hormone excess and, when recognized, can lead to earlier diagnosis.
With ongoing care, many people maintain good quality of life, returning to work or family routines between treatments and check-ins. Understanding the prognosis can guide planning and support choices about surgery, medications, clinical trials, and follow‑up imaging. Talk with your doctor about what your personal outlook might look like. Regular monitoring of hormones and imaging helps catch recurrence early, manage side effects, and adjust therapy so you can stay as active and independent as possible.
Long-term effects
Adrenal gland cancer can affect health for years, both from the tumor itself and from treatments. Long-term effects vary widely, and depend on tumor stage, whether hormones were involved, and the type of treatment you had. Many people do well after surgery, while others may face ongoing issues like hormone imbalance or fatigue. Regular follow-up helps catch changes early and guide care over time.
Tumors that make hormones can leave lasting effects on blood pressure, blood sugar, and mood even after treatment. It can take time for hormone levels to settle, and some people need ongoing medication. Care teams often monitor levels for months to years.
High blood pressure may continue or return if hormone levels stay off balance. Medicines and hormone control often help keep it stable. Rarely, low blood pressure can occur after treatment if hormone levels drop too far.
Cortisol-related tumors can lead to long-term insulin resistance, higher blood sugar, and weight gain. These changes may improve after treatment, but not always completely. Doctors often track glucose and cholesterol over time.
If one or both adrenal glands are removed or damaged, the body may not make enough cortisol. This can cause fatigue, dizziness, or low blood pressure, especially during illness or stress. Many people need lifelong steroid replacement with sick-day plans.
How is it to live with Adrenal gland cancer?
Living with adrenal gland cancer often means juggling treatment schedules, fluctuating energy, and symptoms driven by hormone changes, like high blood pressure, weight shifts, mood swings, or muscle weakness. Daily life can feel unpredictable at first, but many find a steadier rhythm once a treatment plan is in place and symptoms are managed. Partners, family, and coworkers may notice changes in mood or stamina; clear communication and practical support—rides to appointments, help with meals, flexible work hours—can make a real difference. Staying connected with an oncology team, asking about symptom control, and leaning on support groups can help you feel more in control day to day.
Treatment and drugs
Treatment for adrenal gland cancer depends on the tumor type (hormone‑producing or not), stage, and your overall health. Surgery to remove the adrenal gland is the main treatment when the cancer is confined to the gland; if it has spread, surgeons may still remove the primary tumor and any reachable metastases to help with symptoms and control. Medicines that target adrenal cancer cells, such as mitotane, and standard chemotherapy are often used when surgery isn’t possible or after surgery to lower the risk of return; radiation may be added to treat pain or specific spots. Treatment plans often combine several approaches, and care at a center experienced with adrenal tumors can help coordinate surgery, oncology drugs, and hormone management. Ask your doctor about the best starting point for you, including how to replace or block hormones if the tumor or its treatment affects your body’s hormone balance.
Non-drug treatment
Non-drug treatments for adrenal gland cancer focus on removing or controlling the tumor, easing symptoms, and supporting day-to-day life during and after care. Alongside medicines, non-drug therapies can improve comfort, energy, and recovery. These approaches range from surgery and radiation to rehab, nutrition, and counseling, and they can be combined. For some, treatment options for adrenal gland cancer without chemotherapy still provide strong control of disease and symptoms.
Removing the adrenal gland (adrenalectomy) is the main treatment when cancer is confined to the gland. Surgeons may use a keyhole approach for smaller tumors or an open operation for larger or invasive ones. Choosing an experienced center can lower complications and improve outcomes.
Targeted external radiation can control remaining cancer, treat spots that have spread, and ease pain. Stereotactic techniques deliver high-dose beams precisely, often over a few sessions. Radiation therapy for adrenal gland cancer may be used after surgery or for symptom relief.
Needle-based treatments use heat, cold, or other energy to destroy small tumors when surgery isn’t possible. These procedures are image-guided and usually done through the skin. Not every tumor location is suitable, so specialists review safety first.
Regular scans and hormone checks watch for recurrence after treatment. This follow-up can catch changes early and guide next steps. Your schedule is tailored to tumor type, stage, and risk.
Your genes may have an impact on how drugs work for you
Medicines for adrenal gland cancer can work differently depending on your genes, which influence how quickly you break down a drug and how sensitive your tumor cells are to it. Genetic testing sometimes guides dosing or drug choice to improve benefit and reduce side effects.
Pharmacological treatments
Medicines for adrenal gland cancer aim to shrink tumors, slow growth, and control hormone surges that cause symptoms like weight gain, high blood pressure, or diabetes. While surgery is central, drug therapy is often used when cancer has spread or returns. Not everyone responds to the same medication in the same way. Medicines can also ease hormone-related issues, which is especially helpful when early symptoms of adrenal gland cancer lead to faster diagnosis and treatment.
This adrenal‑targeting drug can shrink tumors and lower cortisol levels. It often causes adrenal insufficiency, so most people need steroid replacement. Regular blood tests guide dose adjustments.
A common first combination is etoposide, doxorubicin, and cisplatin given with mitotane. It aims to control fast‑growing adrenal cortical carcinoma and relieve symptoms. Side effects are managed with anti‑nausea drugs and careful monitoring.
If EDP-M is not suitable, doctors may use cisplatin or carboplatin with other agents. Choices depend on prior therapy and overall health. Dosing may be increased or lowered gradually to balance benefit and side effects.
This pair is sometimes used after first‑line chemotherapy stops working. It may slow growth and ease pressure‑related pain. Labs and scans help check response.
Genetic influences
Genes can influence who develops adrenal gland cancer, though most cases are not inherited. Patterns like several relatives with related cancers, a diagnosis in childhood or early adulthood, or tumors affecting both adrenal glands can point more strongly to an inherited cause. A small share of adrenal gland cancers happen as part of well-known inherited syndromes—such as Li-Fraumeni, Lynch, or multiple endocrine neoplasia type 2—which raise lifetime risk. Having a genetic risk is not the same as having the disease itself. If your history suggests this, genetic testing for adrenal gland cancer and a visit with a genetic counselor can clarify your personal risk and guide screening for you and close relatives. Results can also help your care team tailor follow-up, and in some cases may inform treatment choices.
Is Adrenal gland cancer genetic?
Genetics play a meaningful role in adrenal gland cancer, though most cases are not inherited. Certain inherited syndromes and gene changes can raise risk or shape tumor behavior. Genetic testing may guide surveillance, treatment choices, and inform family members’ risk.
Pharmacogenetics—how genetics influence drug effects
Treatment choices and dosing can be shaped by both your genes and the tumor’s genes in adrenal gland cancer. Genes can influence how quickly you process mitotane, a mainstay drug for many with this cancer, which can affect how much you need and how soon you reach the target blood level. Because mitotane levels vary widely between people, doctors often check blood levels and may consider genetic information about drug‑breaking enzymes to fine‑tune dosing.
Tumor testing in adrenal gland cancer can also steer therapy. If the cancer shows certain changes, like defects in DNA repair (mismatch repair deficiency) or rare targetable fusions, immunotherapy or a matched targeted drug may be options in addition to standard chemotherapy. Your own inherited genes may also change your risk of side effects from medicines used with mitotane, such as cisplatin, doxorubicin, and etoposide; this can guide closer heart, kidney, and hearing monitoring or dose adjustments. When appropriate, doctors can use genetic testing to guide adrenal gland cancer treatment—selecting drugs, setting a starting dose, and planning monitoring.
Interactions with other conditions
Hormone-producing adrenal tumors can drive up blood pressure, raise blood sugar, and thin the bones, so existing hypertension, type 2 diabetes, or osteoporosis may suddenly feel harder to control. A condition may “exacerbate” (make worse) symptoms of another. When excess cortisol is released, infections and blood clots become more likely and glucose levels climb, which can strain the heart and complicate diabetes care; medicines for blood pressure or glucose often need adjustment. If the tumor makes aldosterone, stubborn high blood pressure and low potassium can worsen heart or kidney problems and cause muscle weakness that overlaps with other conditions, making early symptoms of adrenal gland cancer easy to miss. Some people with inherited syndromes, such as Li-Fraumeni or Beckwith–Wiedemann, face a higher chance of adrenal gland cancer alongside other tumors, so family history can shape how doctors look for overlapping risks. Treatment can also interact with other diseases: steroid replacement after surgery can affect infection risk and blood sugar control, and chemotherapy or immunotherapy may influence how blood thinners or heart medicines work, so coordinated care across specialties is important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns that were hard to name: a relative who tired easily, lost weight without trying, and developed darkening skin, or a neighbor whose blood pressure swung from very high to dangerously low. Long before scans and lab tests, these stories hinted that something deep inside the body’s stress-response system could go wrong. Caregivers in the past focused on easing symptoms—salt broths for faintness, rest for exhaustion—without knowing the adrenal glands were involved.
Throughout history, people have described sudden illnesses that today sound like adrenal crises. Doctors saw unusual combinations of signs—muscle weakness, abdominal pain, and changes in skin tone—but the small adrenal glands, perched atop the kidneys, remained hidden and mysterious. From early written records to modern studies, the picture slowly shifted from scattered symptom lists to a clearer understanding that growths in these glands could drive illness.
First described in the medical literature as tumors found during autopsy, adrenal gland cancer entered medical awareness as surgeons and pathologists started looking closely at the adrenal glands in the 19th and early 20th centuries. Initially understood only through symptoms, later it became linked to hormone excess when physicians noticed people with severe high blood pressure, facial fullness, or new-onset diabetes that improved after an adrenal mass was removed. Over time, descriptions became more precise: some adrenal tumors made too much cortisol or androgens, while others did not make hormones at all but still grew and spread.
With each decade, advances in imaging—first X‑rays, then ultrasound, CT, and MRI—allowed doctors to see adrenal masses during life, not just after death. This changed care. What was once found late could be detected earlier, sometimes by chance during a scan done for another reason. Surgical techniques improved too, moving from large open operations to refined approaches that helped remove tumors more safely when possible.
Genetics brought another turning point. DNA research now explains why adrenal gland cancer can appear in certain families and in people with specific inherited conditions. Clinicians learned to look for patterns—cancers at younger ages, multiple tumors, or related endocrine issues—so relatives could be offered counseling and, when appropriate, screening. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, awareness has grown that adrenal gland cancer is rare, serious, and varied. Some tumors are slow growing; others behave aggressively. Pathology standards matured, guiding how experts judge a tumor’s behavior under the microscope. Treatments expanded beyond surgery to include medicines that lower hormone effects and therapies that target tumor cells.
Looking back helps explain why early symptoms of adrenal gland cancer were often missed and why modern care relies on a team: endocrinologists, surgeons, oncologists, genetic counselors, and pathologists. Each stage in history has added to the picture we have today—one that blends careful listening to symptoms with precise tests to find the right diagnosis and plan.